Literature DB >> 8273383

Amiodarone-induced thyrotoxicosis: is there a place for surgery?

M Meurisse1, E Hamoir, M D'Silva, J Joris, G Hennen.   

Abstract

Amiodarone-induced hyperthyroidism has on most instances been reported as mild, and thyroid functions return to normal after discontinuation of the drug. Nevertheless, life-threatening amiodarone-induced thyrotoxicosis has also been described. Conventional treatments such as antithyroid drugs (thionamide) and corticosteroids are essentially ineffective or fail to alter the dramatic course of the thyroid crisis. This limited effectiveness of medical therapy, particularly in patients with previously neglected or unknown thyroid disease, prompted us to intervene surgically. We report a series of nine patients who underwent total or near-total thyroidectomy as a first-line therapy for five of them. Surgery resulted in rapid resolution of thyrotoxicosis with an uneventful postoperative course. This approach has the advantage of immediate effectivity, low risk of relapse, and appears to be the only treatment that permits continued therapy with amiodarone when the drug appears needed to control a life-threatening arrhythmia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8273383     DOI: 10.1007/bf01659125

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

Review 1.  Failure to respond to dexamethasone with fatal consequences, after initial response to multidrug treatment in a case of amiodarone-associated thyrotoxicosis.

Authors:  R Peche; M Abramowicz; J Unger
Journal:  Am J Med       Date:  1992-12       Impact factor: 4.965

2.  [Severe hyperthyroidism induced by iodine: a medicosurgical emergency].

Authors:  G Hennen; L Mary-Rabine; M Meurisse
Journal:  Rev Med Liege       Date:  1992-05

3.  Treatment of severe iodine-induced hyperthyroidism with plasmapheresis.

Authors:  O Segers; H Spapen; L Steenssens; R Cytryn; M H Jonckheer; L Vanhaelst
Journal:  Acta Clin Belg       Date:  1988       Impact factor: 1.264

4.  Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

Authors:  M B Rosenbaum; P A Chiale; D Ryba; M V Elizari
Journal:  Am J Cardiol       Date:  1974-08       Impact factor: 2.778

5.  Drug interactions with amiodarone.

Authors:  F I Marcus
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

6.  Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; M Lenziardi; L Baschieri; L E Braverman; A Pinchera
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

7.  [Indications for subtotal thyroidectomy in patients with amiodarone- (iodine-) induced hyperthyroidism].

Authors:  H C Blossey; W Peitsch
Journal:  Wien Med Wochenschr       Date:  1988-09-30

Review 8.  Amiodarone: historical development and pharmacologic profile.

Authors:  B N Singh
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

9.  Iodine treatment of iodine-induced thyrotoxicosis.

Authors:  T M Boehm; J McLain; K D Burman; R deShazo; L Wartofsky
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

Review 10.  Iodide-induced thyrotoxicosis.

Authors:  J E Fradkin; J Wolff
Journal:  Medicine (Baltimore)       Date:  1983-01       Impact factor: 1.889

View more
  5 in total

1.  Management of amiodarone-related thyroid problems.

Authors:  Shashithej K Narayana; David R Woods; Christopher J Boos
Journal:  Ther Adv Endocrinol Metab       Date:  2011-06       Impact factor: 3.565

Review 2.  Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.

Authors:  C M Newman; A Price; D W Davies; T A Gray; A P Weetman
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

Review 3.  [Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?].

Authors:  C Meerwein; D Vital; M Greutmann; C Schmid; G F Huber
Journal:  HNO       Date:  2014-02       Impact factor: 1.284

Review 4.  Drug-induced thyroid disorders.

Authors:  N J Gittoes; J A Franklyn
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

5.  Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases.

Authors:  Agata Czarnywojtek; Maria Teresa Płazińska; Małgorzata Zgorzalewicz-Stachowiak; Kosma Woliński; Adam Stangierski; Izabela Miechowicz; Joanna Waligórska-Stachura; Paweł Gut; Leszek Królicki; Maja Zioncheck; Marek Ruchała
Journal:  Ther Clin Risk Manag       Date:  2016-04-04       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.